Reach Our Drug Product Services Experts:
Lonza’s Drug Product
Services team is highly skilled in the development of biopharmaceuticals including
standard monoclonal antibodies, recombinant proteins, fusion proteins,
antibody-drug-conjugates, and vaccines, as well as viral- and cell-based
development services are available for liquid and lyophilized drug product
dosage forms and are performed integrating relevant container closure systems
such as vials, stoppers and caps or syringes and appropriate drug product
process manufacturing designs.
offerings comprise the complete array of development activities:
is provided for:
Product Services team works closely with the Drug Substance sites across the
Lonza network enabling an integrated and high quality One-Stop-Shop from a
single service provider.
are available as standalone services.